Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum chloroquine resistance transporter (PfCRT) is a 10-transmembrane domain protein located in the membrane of the parasite's acidic digestive vacuole. Under physiological conditions, wild-type PfCRT functions as a nutrient transporter, exporting host hemoglobin-derived oligopeptides and amino acids into the parasite cytosol to maintain osmotic homeostasis and support growth. However, specific point mutations in PfCRT, most notably the K76T substitution, confer resistance to the antimalarial drug chloroquine and related quinoline compounds. These mutations alter the transporter's substrate specificity, enabling it to actively efflux protonated antimalarial drugs out of the digestive vacuole, thereby preventing them from inhibiting heme detoxification. Consequently, PfCRT is a critical mediator of drug resistance in malaria and serves as a key target for developing resistance-reversing agents and novel antimalarial therapies.
Mutant PfCRT acts as a drug efflux pump that transports protonated chloroquine and other quinoline-like antimalarials out of the acidic digestive vacuole of the parasite, reducing drug accumulation at its site of action. In contrast, wild-type PfCRT functions as a nutrient transporter that exports host hemoglobin-derived oligopeptides and amino acids to maintain osmotic homeostasis and support parasite growth.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum chloroquine resistance transporter (PfCRT).